PWM
ABBV icon

Palumbo Wealth Management’s AbbVie ABBV Stock Holding History

Palumbo Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
1,134
-93
-8% -$20K 0.06% 196
2026
Q1 		$267K Buy
1,227
+87
+8% +$19.3K 0.07% 185
2025
Q4 		$261K Buy
+1,140
New +$260K 0.06% 187

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Palumbo Wealth Management's ABBV Position: Q2 2026 in Review

Palumbo Wealth Management reduced its AbbVie (ABBV) stake by 7.6% in Q2 2026, selling an estimated $20K and leaving 1,134 shares worth $285K. The position accounts for 0.06% of the portfolio, ranked #196.

Palumbo Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Palumbo Wealth Management held 1,134 shares of AbbVie worth $285K as of Q2 2026.
  • Palumbo Wealth Management sold 93 AbbVie shares in Q2 2026, an estimated $20K.
  • AbbVie made up 0.06% of Palumbo Wealth Management's portfolio in Q2 2026, its #196 holding.
  • Palumbo Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.